financetom
Business
financetom
/
Business
/
Market Chatter: CVS Health Defers Offering COVID-19 Vaccines in 16 States
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: CVS Health Defers Offering COVID-19 Vaccines in 16 States
Aug 29, 2025 5:13 AM

07:55 AM EDT, 08/29/2025 (MT Newswires) -- CVS Health ( CVS ) is currently holding off on offering COVID-19 vaccines in 16 states due to the "current regulatory environment," The New York Times reported Friday, citing company spokesperson Amy Thibault.

The company is waiting until the Advisory Committee on Immunization Practices recommends the vaccines before offering them nationwide, as pharmacists in some states are not allowed to administer them without the endorsement, the spokesperson told the news outlet.

According to the report, the states where CVS is not currently offering the vaccines are Arizona, Colorado, Florida, Georgia, Kentucky, Louisiana, Maine, Massachusetts, Nevada, New Mexico, New York, North Carolina, Pennsylvania, Utah, Virginia and West Virginia, along with the District of Columbia.

CVS did not immediately reply to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AbbVie cuts 2024 profit forecast on R&D expenses
AbbVie cuts 2024 profit forecast on R&D expenses
Jul 3, 2024
July 3 (Reuters) - AbbVie ( ABBV ) lowered its 2024 adjusted profit forecast on Wednesday, citing $937 million in milestones, and research and development expenses related to acquisitions. The drugmaker has been focusing on expanding its pipeline since its blockbuster arthritis drug, Humira, lost patent protection last year. The company expects annual adjusted profit in the range of $10.61...
PE firm New Mountain values R1 RCM at nearly $6 bln in take-private deal
PE firm New Mountain values R1 RCM at nearly $6 bln in take-private deal
Jul 3, 2024
July 3 (Reuters) - Private-equity firm New Mountain Capital has submitted a buyout proposal for healthcare services provider R1 RCM ( RCM ) in an all-cash deal, valuing the company at nearly $6 billion as per a filing on Tuesday. New Mountain Capital submitted an all-cash proposal to acquire all of the Utah-based company's outstanding shares it does not already...
Nano Dimension Shares Jumped 16% Today: What Happened?
Nano Dimension Shares Jumped 16% Today: What Happened?
Jul 3, 2024
Nano Dimension Ltd. ( NNDM ) shares traded higher on Wednesday after the company announced preliminary second-quarter results and a strategic acquisition of Desktop Metal ( DM ). What Happened: Nano Dimension ( NNDM ) said it expects to report consolidated revenues of approximately $14.8 million for the second quarter, marking an 11% increase from the previous quarter. The strong...
Payoneer Global Insider Sold Shares Worth $3,859,806, According to a Recent SEC Filing
Payoneer Global Insider Sold Shares Worth $3,859,806, According to a Recent SEC Filing
Jul 3, 2024
03:37 PM EDT, 07/03/2024 (MT Newswires) -- Scott H. Galit, Director, on July 01, 2024, sold 709,932 shares in Payoneer Global ( PAYO ) for $3,859,806. Following the Form 4 filing with the SEC, Galit has control over a total of 2,122,421 shares of the company, with 2,122,421 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1845815/000095010324009651/xslF345X03/dp214184_4-galit.xml Price: 5.47, Change: +0.01, Percent Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved